Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03636139
Other study ID # tDCS_BPD
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2016
Est. completion date June 2017

Study information

Verified date February 2024
Source Freie Universität Berlin
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Borderline personality disorder (BPD) is characterized by impairments in the cognitive control of negative information. These impairments in cognitive control are presumably due to blunted activity of the dorsolateral prefrontal cortex (dlPFC) along with enhanced activations of the limbic system. However, the impact of an excitatory stimulation of the dlPFC still needs to be elucidated. In the present study, we therefore assigned 50 patients with BPD and 50 healthy controls to receive either anodal or sham stimulation of the right dlPFC in a double-blind, randomized, between-subjects design.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date June 2017
Est. primary completion date June 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria Borderline Personality Disorder: - Diagnosis of borderline personality disorder Exclusion Criteria Borderline Personality Disorder: - Diagnosis of current or previous bipolar disorder - Diagnosis of current substance dependency - Diagnosis of current major depression - Diagnosis of current or previous neurological disorders (e.g., epilepsy) - Tattoos or scarred skin on the left shoulder or scalp (i.e. F4) Inclusion Criteria Control Participants: - No current or previous diagnosis of a mental disorder Exclusion Criteria Control Participants: - More than 2 criteria of borderline personality disorder are met - Diagnosis of current or previous neurological disorders (e.g., epilepsy) - Intake of psychotropic medication - Tattoos or scarred skin on the left shoulder or scalp (i.e. F4)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
transcranial DC stimulation : anodal
anodal stimulation of the right dlPFC (i.e. F4) for 20 minutes
transcranial DC stimulation : sham
sham stimulation of the right dlPFC (i.e. F4) for 20 minutes

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Freie Universität Berlin

Outcome

Type Measure Description Time frame Safety issue
Primary Response latencies Response latencies were measured in the context of a delayed working memory task. In this paradigm, each trial started with a fixation cross (1000 ms), followed by the presentation of six target letters (1500 ms), which participants were asked to memorize. After a variable distracter period (i.e., interference duration of 1000, 2000, or 4000 ms), participants were presented a recognition display (until a response was made) and had to decide whether the presented letter was part of the initial set of letters. In half of the trials, the recognition display contained a previously presented target. The distracter period of the experimental paradigm was manipulated with regard to the factors valence (grey background screen, or neutral, or negative stimuli) and interference duration (1000, 2000, or 4000 ms). Neutral and negative affective stimuli were selected from the International Affective Picture System. Response latencies were exclusively measured during the assigned interventions, which lasted approx. 20 minutes. No further time points were assessed.
See also
  Status Clinical Trial Phase
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Active, not recruiting NCT04587518 - Five Factor Model Treatment for Borderline Personality Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Completed NCT03677037 - The Short-Term MBT Project Phase 3
Not yet recruiting NCT05989529 - Delving Into Borderline Personality Disorder Clinical Trial Experiences
Completed NCT02518906 - Evaluation of AIT Study N/A
Completed NCT02068326 - MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Terminated NCT02149823 - Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Phase 1
Completed NCT02108990 - Acetaminophen and Social Processes Phase 2
Completed NCT02988037 - Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study N/A
Not yet recruiting NCT01683136 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder N/A
Completed NCT01635556 - Evaluation of a Modified Dialectical Behavior Therapy Program N/A
Completed NCT02397031 - Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder N/A
Terminated NCT01212588 - Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) Phase 2
Terminated NCT01103180 - Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder Phase 2
Terminated NCT00539188 - N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD Phase 2
Recruiting NCT05398627 - Neurofeedback for Borderline Personality Disorder N/A
Recruiting NCT03994510 - SHame prOpensity in bOrderline Personality Disorder N/A
Recruiting NCT06005129 - Personality Change Study for Borderline Personality Disorder N/A